Page 37 - 南京医科大学学报自然科学版
P. 37
第41卷第3期 侯德强,白 宁,魏子程,等. CD109在口腔鳞状细胞癌中的表达及其临床意义[J].
2021年3月 南京医科大学学报(自然科学版),2021,41(03):339-343 ·343 ·
AJCC分期显著相关,CD109高表达在发生淋巴结转 type in vivo[J]. Genes Cells,2018,23(7):590-598
移、远处转移或 AJCC(Ⅲ+Ⅳ)期患者中更为常见。 [7] HATSUZAWA Y,YAMAGUCHI K,TAKANASHI T,et
这些结果表明CD109可能参与了OSCC的转移。 al. CD109 promotes the tumorigenic ability and metastatic
目前关于 CD109 表达对癌症患者预后影响的 motility of pancreatic ductal adenocarcinoma cells[J].
Pancreatology,2020,20(3):493-500
研究结果存在矛盾。在黏液纤维肉瘤、软组织肉瘤和
[8] CHUANG C H,GREENSIDE P G,ROGERS Z N,et al.
肝细胞癌中,CD109 高表达与较差的预后相关 [3,17] 。
Molecular definition of a metastatic lung cancer state re⁃
此外,在弥漫大B细胞淋巴瘤患者中,CD109高表达
veals a targetable CD109⁃Janus kinase⁃stat axis[J]. Nat
与 1 年生存率低显著相关 [18] ,而 CD109 在移行细胞 Med,2017,23(3):291-300
癌患者中的表达与较好的预后相关 [10] 。本研究中 [9] HAGIKURA M,MURAKUMO Y,HASEGAWA M,et al.
单因素Cox回归分析显示CD109表达、肿瘤大小、淋 Correlation of pathological grade and tumor stage of uro⁃
巴结状态、远处转移、AJCC 分期与 OSCC 患者生存 thelial carcinomas with CD109 expression[J]. Pathol Int,
期相关。多因素分析进一步证实CD109表达、淋巴 2010,60(11):735-743
结转移、AJCC 分期是影响OSCC 患者预后的独立因 [10] HAUN R,FAN C,MACKINTOSH S,et al. CD109 overex⁃
pression in pancreatic cancer identified by cell ⁃ surface
素。Kaplan⁃Meier 生存曲线证明了CD109水平高预
glycoprotein capture[J]. J Pro Bio,2014(suppl 10):1-6
示着较短的总生存期。以上结果表明,CD109 表达
[11] OHSHIMA Y,YAJIMA I,KUMASAKA M Y,et al. CD109
水平与OSCC患者预后密切相关。
expression levels in malignant melanoma[J]. J Dermatol
综上所述,本研究证明了 CD109 在 OSCC 组织
Sci,2010,57(2):140-142
中高表达,且CD109高表达的OSCC患者预后较差, [12] DONG F,LIU F,YAN S,et al. Elevated expression of
证实了CD109与OSCC的发生发展及预后有一定相 CD109 in esophageal squamous cell carcinoma [J].
关性。CD109 有望成为新的 OSCC 预后标志物,但 Pathol Oncol Res,2015,21(4):1273-1275
其在OSCC中的作用机制仍需进一步研究。 [13] HAGIWARA S,MURAKUMO Y,SATO T,et al. Up⁃regu⁃
lation of CD109 expression is associated with carcinogen⁃
[参考文献]
esis of the squamous epithelium of the oral cavity[J].
[1] 袁 毅,韩 筱,薛明飞,等. 毛蕊花苷通过上调Max蛋 Cancer Sci,2008,99(10):1916-1923
白抑制口腔鳞癌细胞的迁移和侵袭[J]. 南京医科大学 [14] DONG F,LU C,CHEN X,et al. CD109 is a novel marker
学报(自然科学版),2019,39(1):32-36,93 for squamous cell/adenosquamous carcinomas of the gall⁃
[2] LI Y,LOUIS H,GAOL J,et al. Role of TGF⁃β co⁃receptor bladder[J]. Diagn Pathol,2015,10(1):137
CD109 in extracellular matrix production of smooth mus⁃ [15] TAKI T,SHIRAKI Y,ENOMOTO A,et al. CD109 regu⁃
cle cells[J]. Arc Car Dis Sup,2018,10(2):247-248 lates in vivo tumor invasion in lung adenocarcinoma
[3] EMORI M,TSUKAHARA T,MURATA K,et al. Prognos⁃ through TGF⁃β signaling[J]. Cancer Sci,2020,111(12):
tic impact of CD109 expression in myxofibrosarcoma[J]. 4616-4628
J Surg Oncol,2015,111(8):975-979 [16] TAO J,LI H,LI Q,et al. CD109 is a potential target for
[4] ZHANG H,CARNEVALE G,POLESE B,et al. CD109 re⁃ triple⁃negative breast cancer[J]. Tumour Biol,2014,35
strains activation of cutaneous IL⁃17⁃producing γδ T cells (12):12083-12090
by commensal microbiota[J]. Cell Rep,2019,29(2): [17] ZONG G J,XU Z W,ZHANG S S,et al. CD109 mediates
391-405.e5 cell survival in hepatocellular carcinoma cells[J]. Dig
[5] SONG G,FENG T,ZHAO R,et al. CD109 regulates the Dis Sci,2016,61(8):2303-2314
inflammatory response and is required for the pathogene⁃ [18] YOKOYAMA M,ICHINOE M,OKINA S,et al. CD109,a
sis of rheumatoid arthritis[J]. Ann Rheum Dis,2019,78 negative regulator of TGF⁃β signaling,is a putative risk
(12):1632-1641 marker in diffuse large B⁃cell lymphoma[J]. Int J Hema⁃
[6] MII S,HOSHINO A,ENOMOTO A,et al. CD109 deficien⁃ tol,2017,105(5):614-622
cy induces osteopenia with an osteoporosis ⁃ like pheno⁃ [收稿日期] 2020-09-03